Could a ketamine mist lift severe depression fast?
NCT ID NCT06752759
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether inhaling ketamine through a nebulizer can quickly reduce symptoms of moderate to severe depression in hospitalized adults. About 40 participants will receive either ketamine or a placebo (midazolam) and be monitored for changes in depression scores over 8-10 days. The goal is to see if this approach offers a fast-acting treatment option for those in need.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANALGESICS, NON-NARCOTIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maimonides Medical Center
RECRUITINGBrooklyn, New York, 11219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a ketamine boost during surgery slash opioid needs?
- Could online therapy be the future of mental health care?
- Could a low dose of ketamine protect your heart during eye surgery?
- Brain scans may end guesswork in treating stubborn depression
- Can a blend of lemon verbena and saffron curb emotional eating?
- Ketamine for pain: big study launches to see if it really works